IP Verse

Life Technologies Corporation opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Life Technologies Corporation

Patent Number:
EP2944645
Title:
Method For Isolating Nucleic Acids
Applicant:
QIAGEN GMBH
Opposition Date:
Aug 26, 2020
Patent Number:
EP3077072
Title:
Extraction Of Circulating Nucleic Acids
Applicant:
BIOCARTIS N.V.
Opposition Date:
Dec 6, 2019

Latest patents of Life Technologies Corporation opposed by its competitors

Patent:
EP3347491
Grant Date:
Aug 23, 2023
Title:
Purification Of Nucleic Acid From Environmental Or Biological Samples
Oppositions:
1
Patent:
EP3719481
Grant Date:
Mar 29, 2023
Title:
An Optical Instrument For Biological Analysis
Oppositions:
1
Patent:
EP3165600
Grant Date:
Nov 2, 2022
Title:
Cell Culture Medium Comprising Small Peptides
Oppositions:
4
Patent:
EP3438131
Grant Date:
Mar 16, 2022
Title:
Oligosaccharide Modification And Labeling Of Proteins
Oppositions:
2
Patent:
EP3014506
Grant Date:
Jan 22, 2020
Title:
Methods And Systems For Visualizing Data Quality
Oppositions:
1
Patent:
EP3107658
Grant Date:
Jul 4, 2018
Title:
Apparatuses, Systems And Methods For Providing Scalable Thermal Cyclers And Isolating Thermoelectric Devices
Oppositions:
1

Competitors of Life Technologies Corporation

QIAGEN GMBH

BIOCARTIS N.V.

BOEHRINGER INGELHEIM INTERNATIONAL GMBH

Want to track Life Technologies Corporation?

Feel free to send us a message here and we will get back to you